1. Efficacy and safety of secukinumab in the treatment of moderate‐to‐severe plaque psoriasis: a randomized, double‐blind, placebo‐controlled phase II dose‐ranging study. (18th January 2013) Authors: Papp, K.A.; Langley, R.G.; Sigurgeirsson, B.; Abe, M.; Baker, D.R.; Konno, P.; Haemmerle, S.; Thurston, H.J.; Papavassilis, C.; Richards, H.B. Journal: British journal of dermatology Issue: Volume 168:Number 2(2013:Feb.) Page Start: 412 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild‐to‐moderate toenail onychomycosis: results from three randomized studies using double‐blind vehicle‐controlled and open‐label active‐controlled designs. (20th December 2011) Authors: Elewski, B.E.; Ghannoum, M.A.; Mayser, P.; Gupta, A.K.; Korting, H.‐C.; Shouey, R.J.; Baker, D.R.; Rich, P.A.; Ling, M.; Hugot, S.; Damaj, B.; Nyirady, J.; Thangavelu, K.; Notter, M.; Parneix‐Spake, A.; Sigurgeirsson, B. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 27:Number 3(2013:Mar.) Page Start: 287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗